ReviewFrontiers in immunology2026

Molecular subgroups and biomarker guided precision immunotherapy in triple-negative breast cancer: advances, challenges, and future directions.

Shunhao Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.